• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insiders Buying Westrock Coffee And 3 Other Stocks

    12/4/23 6:42:20 AM ET
    $EP
    $HHH
    $PLSE
    $WEST
    Oil & Gas Production
    Energy
    Real Estate Investment Trusts
    Real Estate
    Get the next $EP alert in real time by email

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Empire Petroleum

    • The Trade: Empire Petroleum Corporation (NYSE:EP) 10% owner Energy Evolution Master Fund Ltd acquired a total of 1,256,832 shares an average price of $8.00. To acquire these shares, it cost around $10.05 million.
    • What’s Happening: On Nov. 13, Empire Petroleum Reported product revenue of $10.3 million and a net loss of $2.7 million for the third quarter.
    • What Empire Petroleum Does: Empire Petroleum Corp is engaged in the exploration and development of oil and natural gas in the United States.

    Pulse Biosciences

    • The Trade: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Robert Duggan acquired a total of 220,267 shares at an average price of $9.35. To acquire these shares, it cost around $2.06 million.
    • What’s Happening: Pulse Biosciences recently said it has received all regulatory approvals and it has substantially completed all required activities to commence its planned catheter ablation feasibility study.
    • What Pulse Biosciences Does: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue.

    Don’t forget to check out our premarket coverage here

    Howard Hughes Holdings

    • The Trade: Howard Hughes Holdings Inc. (NYSE:HHH) Director William Ackman bought a total of 145,121 shares at an average price of $74.07. To acquire these shares, it cost around $10.75 million.
    • What’s Happening: On Nov. 6, Howard Hughes posted upbeat results for the third quarter.
    • What Howard Hughes Holdings Does: Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA.

    Westrock Coffee

    • The Trade: Westrock Coffee Company (NASDAQ:WEST) Director Joe T Ford bought a total of 10,000 shares at an average price of $9.25. The insider spent around $92,500 to buy those shares.
    • What’s Happening: On Nov. 9, Westrock Coffee reported worse-than-expected third-quarter sales results and issued guidance.
    • What Westrock Coffee Does: Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world.

     

    Check This Out: Investor Sentiment Increases As S&P 500 Reaches 2023 Record

    Get the next $EP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EP
    $HHH
    $PLSE
    $WEST

    CompanyDatePrice TargetRatingAnalyst
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Westrock Coffee Company
    $WEST
    11/7/2025$10.00 → $7.00Outperform
    Telsey Advisory Group
    Pulse Biosciences Inc
    $PLSE
    7/7/2025$22.00Outperform
    Oppenheimer
    Howard Hughes Holdings Inc.
    $HHH
    6/23/2025$76.00Overweight → Neutral
    Analyst
    Westrock Coffee Company
    $WEST
    11/8/2024$14.00 → $10.00Outperform
    Telsey Advisory Group
    Westrock Coffee Company
    $WEST
    10/7/2024$10.00Buy
    Truist
    Westrock Coffee Company
    $WEST
    9/23/2024$13.00Buy
    Craig Hallum
    Westrock Coffee Company
    $WEST
    5/10/2024$13.00 → $14.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $EP
    $HHH
    $PLSE
    $WEST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mulacek Phil E bought $20,363 worth of shares (6,800 units at $2.99), increasing direct ownership by 0.11% to 6,173,732 units (SEC Form 4)

    4 - EMPIRE PETROLEUM CORP (0000887396) (Issuer)

    1/5/26 5:22:42 PM ET
    $EP
    Oil & Gas Production
    Energy

    Director Mulacek Phil E bought $16,353 worth of shares (5,451 units at $3.00), increasing direct ownership by 0.09% to 6,166,932 units (SEC Form 4)

    4 - EMPIRE PETROLEUM CORP (0000887396) (Issuer)

    12/31/25 5:21:46 PM ET
    $EP
    Oil & Gas Production
    Energy

    Director Sellers R Scot bought $389,713 worth of shares (5,000 units at $77.94), increasing direct ownership by 8% to 67,517 units (SEC Form 4)

    4 - Howard Hughes Holdings Inc. (0001981792) (Issuer)

    12/29/25 5:00:14 PM ET
    $HHH
    Real Estate Investment Trusts
    Real Estate

    $EP
    $HHH
    $PLSE
    $WEST
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/19/26 4:28:11 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form S-3 filed by Pulse Biosciences Inc

    S-3 - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/19/26 4:22:58 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Pulse Biosciences Inc

    S-8 - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/19/26 4:19:44 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $EP
    $HHH
    $PLSE
    $WEST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued on February 18, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4). Pulse has awarded inducement options to two new employees to purchase, in aggregate, up to 19,000 shares of Company common stock. The Company's i

    2/20/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

    Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46th Annual TD Cowen Healthcare Conference in Boston. Pulse Biosciences' Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm ET. A live and recorded webcast of the presentation will be available on the "Events Calendar and Presentations" page of the company's investor website at http://investors.pulsebiosciences.com/. About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intent

    2/20/26 7:00:00 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

    Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2025. Recent Business Highlights Endocardial Catheter AF Ablation Highlighted 100% procedural success, or freedom from atrial fibrillation (AF), at 6 months and 96% procedural success at one year, of evaluable patients, following treatments with the nPulse Cardiac Catheter System in the first-in-human feasibility study which was presented as late-breaking data at the 31st Annual AF Symposium Meeting. Receiv

    2/19/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $EP
    $HHH
    $PLSE
    $WEST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Telsey Advisory Group reiterated coverage on Westrock Coffee Company with a new price target

    Telsey Advisory Group reiterated coverage of Westrock Coffee Company with a rating of Outperform and set a new price target of $7.00 from $10.00 previously

    11/7/25 7:48:21 AM ET
    $WEST
    Beverages (Production/Distribution)
    Consumer Staples

    Oppenheimer initiated coverage on Pulse Biosciences with a new price target

    Oppenheimer initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $22.00

    7/7/25 8:02:36 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $EP
    $HHH
    $PLSE
    $WEST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Danahy Kevin Patrick exercised 60,000 shares at a strike of $1.53 and sold $1,410,600 worth of shares (60,000 units at $23.51) (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/17/26 8:47:42 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Chief Commercial Officer Danahy Kevin Patrick exercised 60,000 shares at a strike of $1.53 and sold $1,403,400 worth of shares (60,000 units at $23.39) (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/11/26 7:46:34 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    General Counsel & Secretary Valane Joseph covered exercise/tax liability with 483 shares, decreasing direct ownership by 2% to 27,949 units (SEC Form 4)

    4 - Howard Hughes Holdings Inc. (0001981792) (Issuer)

    2/9/26 5:21:00 PM ET
    $HHH
    Real Estate Investment Trusts
    Real Estate

    $EP
    $HHH
    $PLSE
    $WEST
    Financials

    Live finance-specific insights

    View All

    Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

    Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2025. Recent Business Highlights Endocardial Catheter AF Ablation Highlighted 100% procedural success, or freedom from atrial fibrillation (AF), at 6 months and 96% procedural success at one year, of evaluable patients, following treatments with the nPulse Cardiac Catheter System in the first-in-human feasibility study which was presented as late-breaking data at the 31st Annual AF Symposium Meeting. Receiv

    2/19/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Howard Hughes Holdings Inc. Reports Fourth Quarter and Full Year 2025 Results

    THE WOODLANDS, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE:HHH) (the "Company," "HHH," "Howard Hughes," or "we") today announced operating results for the fourth quarter ended December 31, 2025. The financial statements, exhibits, and reconciliations of non-GAAP measures in the attached Appendix and the Supplemental Information, as available through the Investors section of our website, provide further detail of these results. Full Year 2025 Highlights: Net income from continuing operations of $123.8 million, or $2.21 per diluted share, in 2025, compared to $285.2 million, or $5.73 per diluted share, in 2024Announced an agreement to acquire 100% of Vantage

    2/19/26 4:01:00 PM ET
    $HHH
    Real Estate Investment Trusts
    Real Estate

    Westrock Coffee Company to Report Fourth Quarter 2025 Financial Results on March 10th, 2026

    LITTLE ROCK, Ark., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Westrock Coffee Company (NASDAQ:WEST) ("Westrock Coffee" or the "Company") today announced that it will report its fourth quarter 2025 results on Tuesday, March 10, 2026 after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the live earnings call and question and answer session, please register HERE and dial-in information will be provided directly to you. The live audio webcast will be accessible in the "Events and Presentations" section of the Company's Investor Relations website at https://investors.westrockcoffee.com. An archived replay of the webcast will be avai

    2/17/26 4:05:00 PM ET
    $WEST
    Beverages (Production/Distribution)
    Consumer Staples

    $EP
    $HHH
    $PLSE
    $WEST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Empire Petroleum Corporation

    SC 13D/A - EMPIRE PETROLEUM CORP (0000887396) (Subject)

    11/27/24 4:05:52 PM ET
    $EP
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13D/A filed by Howard Hughes Holdings Inc.

    SC 13D/A - Howard Hughes Holdings Inc. (0001981792) (Subject)

    8/6/24 9:50:32 PM ET
    $HHH
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Howard Hughes Holdings Inc.

    SC 13D/A - Howard Hughes Holdings Inc. (0001981792) (Subject)

    7/25/24 9:45:30 PM ET
    $HHH
    Real Estate Investment Trusts
    Real Estate

    $EP
    $HHH
    $PLSE
    $WEST
    Leadership Updates

    Live Leadership Updates

    View All

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Howard Hughes Holdings Announces Appointment of Thom Lachman and Susan Panuccio to Board of Directors

    THE WOODLANDS, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Howard Hughes Holdings (NYSE:HHH) today announced the appointment of Thom Lachman and Susan Panuccio as independent Directors of the Company. "Thom and Susan both bring tremendous expertise and proven track records of delivering growth and long-term value creation, and we are delighted to welcome them to the Board," said Bill Ackman, Executive Chairman of Howard Hughes Holdings. "Thom's operational excellence and leadership in global consumer brands, and Susan's deep experience in corporate strategy and financial transformation will be invaluable as the company diversifies and grows into the next great diversified holding company."

    9/30/25 4:02:48 PM ET
    $HHH
    Real Estate Investment Trusts
    Real Estate

    Seaport Entertainment Group Names Matt Partridge President and Chief Executive Officer

    Anton Nikodemus to Remain with SEG as Special Advisor Seaport Entertainment Group Inc. (NYSE:SEG) ("Seaport Entertainment Group," "SEG", "we," "our," or the "Company") announced today the appointment of Matt Partridge as President and Chief Executive Officer. Mr. Partridge will succeed Anton Nikodemus, who will remain with the Company as a Special Advisor until November 3, 2025. Additionally, the Company's Chief Accounting Officer, Lenah Elaiwat, was named Interim Chief Financial Officer and Treasurer, and Michael Crawford, currently Lead Independent Director of the Company's Board of Directors, will become Chairman of the Board. "It is an honor to step into this role," said Mr. Partrid

    9/10/25 7:55:00 AM ET
    $HHH
    $SEG
    Real Estate Investment Trusts
    Real Estate
    Services-Misc. Amusement & Recreation
    Consumer Discretionary